<i>Epi</i>-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses-Reference-Cited by-同舟云学术

Epi-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses

Published:2024-07-25 Issue:8 Volume:10 Page:1594-1608
ISSN:2374-7943
Container-title:ACS Central Science
language:en
Short-container-title:ACS Cent. Sci.

Author:

Thaler Melissa¹,Ofman Tim P.²,Kok Ken²,Heming Jurriaan J. A.²,Moran Elisha³^ORCID,Pickles Isabelle³^ORCID,Leijs Anouk A.¹,van den Nieuwendijk Adrianus M. C. H.²,van den Berg Richard J. B. H. N.²,Ruijgrok Gijs²,Armstrong Zachary²^ORCID,Salgado-Benvindo Clarisse¹,Ninaber Dennis K.⁴,Snijder Eric J.¹,van Boeckel Constant A. A.²,Artola Marta²^ORCID,Davies Gideon J.³^ORCID,Overkleeft Herman S.²^ORCID,van Hemert Martijn J.¹^ORCID

Affiliation:

1. Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands

2. Leiden Institute of Chemistry, Leiden University, 2311 EZ Leiden, The Netherlands

3. Department of Chemistry, University of York, York YO10 5DD, United Kingdom

4. Department of Pulmonology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands

Funder

Royal Society

Exacte en Natuurwetenschappen

European Research Council

Minist?rio da Educa??o

Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

Publisher